The University of Southampton
University of Southampton Institutional Repository

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke

Multiple sclerosis (MS) and stroke pathology are characterized by blood-brain barrier breakdown, leucocyte emigration, and tissue destruction. Each process is thought to involve the matrix metalloproteinases (MMP), but little is known of their expression. We undertook to investigate whether MMP expression is dependent on the nature of the CNS lesion and whether expression would coincide with the histopathology. MS or cerebral-infarct tissue was examined for the presence of gelatinase-A, gelatinase-B, matrilysin and stromelysin-1. Gelatinases A and B and matrilysin expression was found to be up-regulated in microglia/macrophages within acute MS lesions. In active-chronic MS lesions, matrilysin and gelatinase-A expression was pronounced in the active borders. In chronic MS lesions, the expression of matrilysin was confined to macrophages within perivascular cuffs. The pattern of MMP expression in infarct lesions differed considerably. Gelatinase-B was strongly expressed by neutrophils in tissue from patients up to 1 week after an infarct, whereas gelatinase-A and matrilysin staining was much less marked. From 1 week to 5 years, neutrophils were absent and the large number of macrophages present were expressing matrilysin and gelatinase A. Only a low level of gelatinase-A and matrilysin expression was observed in normal brain controls. Thus, MMPs are expressed in inflammatory lesions in the CNS, but their individual expression is dependent on the nature and chronicity of the lesion. However, the general pattern of expression, in perivascular cuffs and in active lesions, supports a role for these enzymes as mediators of blood-brain barrier breakdown and tissue destruction, both in MS and in cerebral ischaemia.

Blood-brain barrier, Metalloproteinase, Multiple sclerosis, Stroke
0305-1846
406-415
Anthony, D.C.
928249fa-dcf4-4088-b95b-ce14c719164d
Ferguson, B.
23e4b1e1-1390-4e10-8cb1-48b77787abda
Matyzak, M.K.
8b7c5f61-2214-49fe-94e6-d1057bcfd244
Miller, K.M.
8442529d-072b-41ff-aa37-a728ec79e37f
Esiri, M.M.
5ddc8b86-8e5a-4eca-a99c-7e59234b24f7
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
et al.
Anthony, D.C.
928249fa-dcf4-4088-b95b-ce14c719164d
Ferguson, B.
23e4b1e1-1390-4e10-8cb1-48b77787abda
Matyzak, M.K.
8b7c5f61-2214-49fe-94e6-d1057bcfd244
Miller, K.M.
8442529d-072b-41ff-aa37-a728ec79e37f
Esiri, M.M.
5ddc8b86-8e5a-4eca-a99c-7e59234b24f7
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4

Anthony, D.C., Ferguson, B. and Matyzak, M.K. , et al. (1997) Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathology and Applied Neurobiology, 23 (5), 406-415. (doi:10.1111/j.1365-2990.1997.tb01315.x).

Record type: Article

Abstract

Multiple sclerosis (MS) and stroke pathology are characterized by blood-brain barrier breakdown, leucocyte emigration, and tissue destruction. Each process is thought to involve the matrix metalloproteinases (MMP), but little is known of their expression. We undertook to investigate whether MMP expression is dependent on the nature of the CNS lesion and whether expression would coincide with the histopathology. MS or cerebral-infarct tissue was examined for the presence of gelatinase-A, gelatinase-B, matrilysin and stromelysin-1. Gelatinases A and B and matrilysin expression was found to be up-regulated in microglia/macrophages within acute MS lesions. In active-chronic MS lesions, matrilysin and gelatinase-A expression was pronounced in the active borders. In chronic MS lesions, the expression of matrilysin was confined to macrophages within perivascular cuffs. The pattern of MMP expression in infarct lesions differed considerably. Gelatinase-B was strongly expressed by neutrophils in tissue from patients up to 1 week after an infarct, whereas gelatinase-A and matrilysin staining was much less marked. From 1 week to 5 years, neutrophils were absent and the large number of macrophages present were expressing matrilysin and gelatinase A. Only a low level of gelatinase-A and matrilysin expression was observed in normal brain controls. Thus, MMPs are expressed in inflammatory lesions in the CNS, but their individual expression is dependent on the nature and chronicity of the lesion. However, the general pattern of expression, in perivascular cuffs and in active lesions, supports a role for these enzymes as mediators of blood-brain barrier breakdown and tissue destruction, both in MS and in cerebral ischaemia.

This record has no associated files available for download.

More information

Published date: October 1997
Keywords: Blood-brain barrier, Metalloproteinase, Multiple sclerosis, Stroke

Identifiers

Local EPrints ID: 489604
URI: http://eprints.soton.ac.uk/id/eprint/489604
ISSN: 0305-1846
PURE UUID: 4223db42-b6ee-4891-b0cf-376097202279

Catalogue record

Date deposited: 29 Apr 2024 16:46
Last modified: 29 Apr 2024 16:46

Export record

Altmetrics

Contributors

Author: D.C. Anthony
Author: B. Ferguson
Author: M.K. Matyzak
Author: K.M. Miller
Author: M.M. Esiri
Author: V.H. Perry
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×